ArticleBioengineering (Basel, Switzerland)2025
The Comparison of Classical Statistical and Machine Learning Methods in Prediction of Thrombosis in Patients with Acute Myeloid Leukemia.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Using Explainable Machine Learning to Identify Determinants of Spinal Deformities in Children: It's Not Only About What, but Also About How.Healthcare (Basel, Switzerland) · 2026Article
- AI-driven big data analysis and predictive modeling of infectious disease immunity: from correlates to causal, multiscale understanding.Archives of microbiology · 2026Review
- Classification of anterior cruciate ligament injury profiles through running analysis: a machine learning approach.Scientific reports · 2026Article
- Development and validation of a leukemia prognostic model through single-cell RNA sequencing and machine learning approaches.Discover oncology · 2025Article
- Applications of Artificial Intelligence in Acute Promyelocytic Leukemia: An Avenue of Opportunities? A Systematic Review.Journal of clinical medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thrombosis is one of the most frequent complications of cancer, with a potential impact on morbidity and mortality, particularly those with acute myeloid leukemia (AML). Therefore, effective thrombosis prevention is a crucial aspect of cancer management. However, preventive measures against thrombosis may carry inherent risks and complications. Consequently, the application of thrombosis prevention should be limited to patients with a reasonable risk of developing thrombosis. This thesis explores the potential of data science (DS) methods for predicting venous thrombosis in patients with acute myeloid leukemia. In order to ascertain which patients are at risk, statistical and machine-learning (ML) algorithms were employed to predict which patients with leukemia will develop thrombosis. Multilayer Perceptron (MLP) was found to be the best fit among the models evaluated, achieving the C statistic of 0.749. We examined which attributes are significant and what role they play in prediction and found six significant parameters: sex of the patient, prior history of thrombotic event, type of therapy, international normalized ratio (INR), Eastern Cooperative Oncology Group (ECOG) performance status, and Hematopoietic Cell Transplantation-specific Comorbidity. These findings suggest that subtle DS techniques can improve the prediction of Thrombosis in AML patients, thereby aiding in individual treatment planning.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.